5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

 

Lung Cancers
09:53

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

2L Options for EGFR+ NSCLC: How to Treat Osimertinib Resistance? What Is the Role of Anti-Angiogenic Therapy?

FEATURING Shayma Kazmi
  • 801 views
  • February 2, 2021
  • 3
15:37

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

Update on Early Stage NSCLC: Role of Screening, Neoadjuvant Therapies (Immune Checkpoint Inhibitors, Neo Chemo/IO) & Durvalumab in Surgically Unresectable Stage III

FEATURING Jason Porter
  • 55 views
  • March 12, 2020
10:32

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

Use of Stereotactic Radiation for NSCLC Pts & Vale of IO after SBRT

FEATURING Wally Curran
  • 68 views
  • March 12, 2020
09:04

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

New RT Approaches to Stage III NSCLC Pts: Can Radiotherapy Be Further Improved? & Ultra-High Dose Rate Radiation

FEATURING Wally Curran
  • 105 views
  • March 12, 2020
  • 1
10:53

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

2020 Update on NSCLC Targeted Therapies: ALK, ROS1, RET, MET, NTRK, KRAS and BRAF

FEATURING Shayma Kazmi
  • 1,550 views
  • March 12, 2020
  • 6
14:33

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

Immunotherapy in NSCLC: Progression, irAE management & Combination Therapies

FEATURING Ravi Salgia
  • 516 views
  • March 12, 2020
  • 2